APA
Boudadi K., Suzman D. L., Anagnostou V., Fu W., Luber B., Wang H., Niknafs N., White J. R., Silberstein J. L., Sullivan R., Dowling D., Harb R., Nirschl T. R., Veeneman B. A., Tomlins S. A., Wang Y., Jendrisak A., Graf R. P., Dittamore R., Carducci M. A., Eisenberger M. A., Haffner M. C., Meeker A. K., Eshleman J. R., Luo J., Velculescu V. E., Drake C. G. & Antonarakis E. S. (2018). Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer. : Oncotarget.
Chicago
Boudadi Karim, Suzman Daniel L, Anagnostou Valsamo, Fu Wei, Luber Brandon, Wang Hao, Niknafs Noushin, White James R, Silberstein John L, Sullivan Rana, Dowling Donna, Harb Rana, Nirschl Thomas R, Veeneman Brendan A, Tomlins Scott A, Wang Yipeng, Jendrisak Adam, Graf Ryon P, Dittamore Ryan, Carducci Michael A, Eisenberger Mario A, Haffner Michael C, Meeker Alan K, Eshleman James R, Luo Jun, Velculescu Victor E, Drake Charles G and Antonarakis Emmanuel S. 2018. Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer. : Oncotarget.
Harvard
Boudadi K., Suzman D. L., Anagnostou V., Fu W., Luber B., Wang H., Niknafs N., White J. R., Silberstein J. L., Sullivan R., Dowling D., Harb R., Nirschl T. R., Veeneman B. A., Tomlins S. A., Wang Y., Jendrisak A., Graf R. P., Dittamore R., Carducci M. A., Eisenberger M. A., Haffner M. C., Meeker A. K., Eshleman J. R., Luo J., Velculescu V. E., Drake C. G. and Antonarakis E. S. (2018). Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer. : Oncotarget.
MLA
Boudadi Karim, Suzman Daniel L, Anagnostou Valsamo, Fu Wei, Luber Brandon, Wang Hao, Niknafs Noushin, White James R, Silberstein John L, Sullivan Rana, Dowling Donna, Harb Rana, Nirschl Thomas R, Veeneman Brendan A, Tomlins Scott A, Wang Yipeng, Jendrisak Adam, Graf Ryon P, Dittamore Ryan, Carducci Michael A, Eisenberger Mario A, Haffner Michael C, Meeker Alan K, Eshleman James R, Luo Jun, Velculescu Victor E, Drake Charles G and Antonarakis Emmanuel S. Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer. : Oncotarget. 2018.